BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

ABR–Affinity BioReagents Announces Its Continued Support for the Society for Neuroscience Annual Meeting in San Diego, November 3 - 7, 2007


11/5/2007 6:50:25 AM

DENVER and GOLDEN, Colo., Nov. 2 /PRNewswire/ -- ABR-Affinity BioReagents, a leading global antibody manufacturer, announced today the company's continued participation at the 37th Annual Society for Neuroscience Meeting in San Diego, California, November 3 - 7, 2007.

After the wildfires of the past week and a half, the influx of meeting participants will hopefully provide a much needed boost to the hard hit economy of the region. "All of the staff at ABR-Affinity BioReagents is hopeful that those in San Diego and the surrounding area who have been displaced by the fires will be able to rebuild and resume their lives as soon as possible. They have our deepest sympathy," said Ken Wilczek, President of ABR.

ABR now offers over 2,600 products for neurobiological research, many of them new since last year's meeting, all of which are supported by ABR's 100% Quality Guarantee. Emerging research on the brain and the nervous system involves overlapping research areas, including vision, nitric oxide synthase, signal transduction and ion transport and regulation. "This is a critical research field, and ABR is proud to be a leading contributor to advances in understanding the nervous system and associated disorders," noted Mr. Wilczek. With attendance predicted to top 30,000 researchers, this is one of the largest meetings in the biotechnology arena. ABR-Affinity BioReagents will be located at booth # 3612 at the upcoming meeting.

About ABR-Affinity BioReagents

Founded in 1989 with world headquarters in Golden, Colorado, ABR-Affinity BioReagents is a world leader in the manufacture and distribution of monoclonal and polyclonal antibodies, kits, recombinant proteins, siRNA, and custom antibody production services, known as Antibody on Demand(R).

With more than 35,000 antibodies focused in 43 research areas, ABR offers a unique value proposition in the life science industry -- research antibodies that are 100% quality guaranteed or your money back -- with no questions asked.

Utilizing a distribution network encompassing over 55 nations, ABR products are readily available in every research market on the globe. Products are available directly from ABR in the United States, as well as through an exclusive distribution partnership with Fisher Scientific, a division of Thermo Fisher Scientific.

For additional information about ABR-Affinity BioReagents, contact Leslie Martin with ABR media relations at 1-800-527-4535.

CONTACT: Leslie Martin of ABR media relations, 1-800-527-4535

Web site: http://www.bioreagents.com/



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->